Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT06100510

Enrolling by invitation

PFA 100 Evaluation and Reference Interval HOACNY

Effect of Drug
NCT05356936

Completed

Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers

Post-acute COVID-19 Syndrome
NCT02848443

Completed

Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
NCT04604132

Terminated

Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma (FIDES-03)

Gastric Adenocarcinoma
NCT01784159

Terminated

ASpirin for Patients With SEPsis and SeptIc Shock (ASP-SEPSIS)

Sepsis
NCT02927249

Terminated

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Node Positive HER2 Negative Breast Cancer
NCT03038100

Completed

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (IMagyn050)

Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer
NCT02350517

Completed

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

Esophageal Squamous Cell Carcinoma
NCT00014443

Terminated

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Brain and Central Nervous System Tumors
NCT02824523

Completed

Role of Inflammatory Mediators in AERD

Asthma, Aspirin-Induced
NCT03395639

Completed

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Cardiac Disease
NCT04040465

Completed

Asprin Dosing Estimator in Healthy Adults

Aspirin Sensitivity
NCT04631627

Unknown

Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort

Preeclampsia
NCT04588220

Unknown

Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM (melatonin&PROM)

Preterm Premature Rupture of Membranes
NCT04380103

Unknown

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

Colorectal Cancer | Metastatic Cancer | Colorectal Adenocarcinoma
NCT04327427

Unknown

Outcome Analysis of Aspirin in Liver Transplantation

Liver Transplant; Complications
NCT03027973

Withdrawn

Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding

Heavy Menstrual Bleeding
NCT01182350

Terminated

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Diffuse Intrinsic Pontine Glioma
NCT00234052

Completed

Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Lung Cancer
NCT02240667

Completed

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Atrial Fibrillation
NCT00043823

Completed

Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer

Lung Cancer
NCT00923936

Completed

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

Sarcoma, Kaposi
NCT00602407

Completed

Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

Intermittent Claudication
NCT00903630

Terminated

Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer
NCT01651806

Completed

Weighted Versus Uniform Dose of Tranexamic Acid in Patients Undergoing Primary, Knee Arthroplasty

Osteoarthritis | Intraoperative Bleeding
NCT00305825

Completed

Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

Breast Cancer
NCT01729871

Completed

A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy (VENTURE-AF)

Atrial Fibrillation
NCT00361231

Completed

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer

Biliary Tract Cancer | Gallbladder Adenocarcinoma
NCT00806923

Completed

A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-Squamous Non-Small Cell Lung Cancer
NCT00417898

Withdrawn

Study of Aspirin and TPA in Acute Ischemic Stroke

Acute Ischemic Stroke
NCT02663141

Completed

Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema

Diabetic Macular Edema
NCT02694848

Unknown

Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection

Angina
NCT00675597

Completed

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

Lung Cancer
NCT01077713

Completed

A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer
NCT01412307

Unknown

A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma (LEBEN)

Recurrent Adult Hodgkin Lymphoma
NCT02497326

Unknown

Heparin for the Treatment of Burn Wound Pain

Second Degree Burns
NCT01618006

Completed

Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)

Postoperative; Dysfunction Following Cardiac Surgery
NCT01902498

Completed

Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B

Postoperative Dysfunction Following Cardiac Surgery
NCT00479674

Completed

Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer (ABC)

Breast Cancer
NCT02195336

Unknown

dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact. (BevMar)

Non-small Cell Lung Cancer
NCT00142467

Completed

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT01263834

Completed

Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome (Bevacizumab)

Glaucoma
NCT00909987

Completed

Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum

Rectum Cancer
NCT01374698

Completed

Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.

Coronary Arteriosclerosis
NCT01125943

Completed

Bevacizumab and Endothelium Dependent Vasodilation

Hypertension | Cancer | Endothelial Dysfunction
NCT00818337

Completed

Aspirin Responsiveness in Women at Risk for Cardiac Events

Heart Disease
NCT01250340

Unknown

Type 2 Diabetes Mellitus and Atherosclerosis

Type 2 Diabetes Mellitus
NCT00790452

Terminated

Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

Glioblastoma
NCT00773630

Completed

A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions

Intermittent Claudication
NCT00407459

Completed

Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma

Mesothelioma

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations